FDA Inspection 947993 — Novartis Pharma Stein AG
The FDA completed an inspection of Novartis Pharma Stein AG on Oct 16, 2015 in Stein Ag. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 16, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Stein Ag (Switzerland)